PDHA2 anticorps (Middle Region)
Aperçu rapide pour PDHA2 anticorps (Middle Region) (ABIN954071)
Antigène
Voir toutes PDHA2 (PDHa2) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 290-318, Middle Region
-
Specificité
- This antibody recognizes Human PDHA2 (Center).
-
Purification
- Protein A column, followed by peptide affinity purification
-
Immunogène
- KLH conjugated synthetic peptide between 290-318 amino acids from the Central region of Human PDHA2
-
Isotype
- Ig Fraction
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.25 mg/mL
-
Buffer
- PBS containing 0.09 % (W/V) Sodium Azide as preservative
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeated freezing and thawing.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- PDHA2 (PDHa2) (Pyruvate Dehydrogenase (Lipoamide) alpha 2 (PDHa2))
-
Autre désignation
- PDHA2
-
Sujet
- The pyruvate dehydrogenase complex catalyzes the overall conversion of pyruvate to acetyl-CoA and CO(2). It contains multiple copies of three enzymatic components: pyruvate dehydrogenase (E1), dihydrolipoamide acetyltransferase (E2) and lipoamide dehydrogenase (E3).Synonyms: PDHAL, PDHE1-A type II, Pyruvate dehydrogenase E1 component subunit alpha testis-specific form mitochondrial
-
Poids moléculaire
- 42933 Da
-
ID gène
- 5161
-
NCBI Accession
- NP_005381
-
Pathways
- L'effet Warburg
Antigène
-